Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles P. Lucas is active.

Publication


Featured researches published by Charles P. Lucas.


Biochimica et Biophysica Acta | 1970

Studies on the partial isolation of human renin

Werner K. Waldhäusl; Charles P. Lucas; Jerome W. Conn; John H. Lutz; Edwin L. Cohen

Abstract Studies on the partial isolation of human renin have been described. We have observed that: 1. 1. Thorough disruption of the cell membranes by an all glass homogenizer increases the yield of enzyme eluted from renal tissue. 2. 2. QAE-Sephadex and calcium gel cellulose chromatography are valuable tools for the purification of renin. Gradient elution is superior in ion exchange chromatography of human renin. The properties of the final preparation obtained (Fraction 9) are: mol. wt. 42 000; isoelectric point pH 5.25; A280 mμ:A260 mμ = 2.1; pH optimum for human substrate 5.5; hog substrate 7.5–8.5; and tetradecapeptide renin substrate 5.5. Specific activity 8.4 Goldblatt units per mg protein (by bioassay in the dog). 3. 3. Evidence was obtained for the existence of considerable amounts of angiotensin I converting enzyme in human kidneys. Problems concerning the standardisation of human renin have been discussed.


Diabetes | 1965

Augmentation of Insulin Activity: Physiological Implications of a Property of Human Serum Revealed by Dilution

Lawrence Power; Charles P. Lucas; Jerome W. Conn; Ann Arbor; John Shuman

Dilution of human serum does not lead to the expected reduction of its insulin-like activity (ILA) as measured by the epididymal fat pad. Dilution of a solution of Crystalline Insulin does, however, reduce activity arithmetically. Because the addition of Crystalline Insulin to diluted serum results in levels of ILA greater than expected (augmentation), the failure of ILA to fall arithmetically with dilution may reflect this augmentation effect on endogenous ILA. The augmentation effect, as revealed by dilution and the addition of Crystalline Insulin, has been shown to increase in the serum of normal subjects after glucose loading, and to be deficient in fasting serum from the untreated diabetic patient.


Metabolism-clinical and Experimental | 1965

Release of insulin-like activity from serum of normal subjects and diabetic patients

Lawrence Power; Charles P. Lucas; Jerome W. Conn

Exposure to acid-ethanol releases intense, previously masked insulin-like activity from the serum of both normal subjects and untreated diabetic patients. In proportion to the level of ILA in intact serum, diabetic serum contains less masked ILA than does normal serum. In terms of total ILA, however, that released from the serum of diabetics exceeds that released from normal serum, both in the fasting state and after glucose loading. The delayed increase of serum ILA after glucose loading, repeatedly observed in diabetics, has been shown to hold true for acid-alcohol releasable ILA as well.


Metabolism-clinical and Experimental | 1975

A Plasma Inhibitor of the Renin-Antirenin Reaction and the In Vitro Generation of Angiotensin I

Charles P. Lucas; Werner K. Waldhäusl; Edwin L. Cohen; F. G. Berlinger; Walter J. Mcdonald; Richard S. Sider

In the course of studies designed to develop a radioimmunoassay system for the detection of renin, we have identified in human plasma a potent inhibitor that interferes with the renin-antirenin reaction. Utilizing gel filtration, this renin-antirenin inhibitory activity was found to have the same molecular size as renin substrate. However, it could be separated from renin substrate by ion-exchange chromatography. When fractions containing this activity were tested in an in vitro system containing renin and renin substrate, they were found to inhibit the generation of angiotensin I.


Metabolism-clinical and Experimental | 1965

A Globulin System from Human Serum that Augments the Activity of Crystalline Insulin on the Epididymal Fat Pad Deficiency in Diabetes Mellitus

Lawrence Power; Charles P. Lucas; Jerome W. Conn

It has been demonstrated that globulin isolated from normal serum augments the action of added crystalline insulin when assayed on the rat epididymal fat pad. This augmentation capacity is very low or absent in globulin from the serum of untreated diabetic patients. The possibility is discussed that these findings may indicate that diabetic patients produce an abnormal form of insulin.


Metabolism-clinical and Experimental | 1965

FURTHER STUDIES ON INSULIN AUGMENTATION CAPACITIES OF VARIOUS SERUM PROTEINS.

Lawrence Power; Charles P. Lucas; Jerome W. Conn

Abstract The ability of human serum protein to augment the action of crystalline insulin on the epididymal fat pad has been further evaluated. Serum proteins were fractionated by elution from DEAE cellulose and the capacity of individual fractions to augment insulin action determined. The property was found to be present in all fractions, but concentrated to a slightly greater extent in the fastermoving gamma globulins and beta globulins. The augmentation effect has again been found to be deficient in diabetes mellitus.


Metabolism-clinical and Experimental | 1965

Some characteristics of the insulin augmentation phenomenon

Lawrence Power; Charles P. Lucas; Jerome W. Conn

Abstract A serum protein fraction possessing the capacity to augment insulin action on adipose tissue in vitro has been isolated and studied. Factors responsible for augmentation have been found to be nondialyzable and susceptible to destruction by ethanol, alkali and heat. The augmentation phenomenon is probably dependent upon the presence of a protein moiety.


JAMA Internal Medicine | 2000

Effects of Weight Loss With Orlistat on Glucose Tolerance and Progression to Type 2 Diabetes in Obese Adults

Steven B. Heymsfield; Karen R. Segal; Jonathan Hauptman; Charles P. Lucas; Mark Boldrin; Aila Rissanen; John Wilding; Lars Sjöström


Archives of Family Medicine | 2000

Orlistat in the Long-term Treatment of Obesity in Primary Care Settings

Jonathan Hauptman; Charles P. Lucas; Mark Boldrin; Harry Collins; Karen R. Segal


The Journal of Clinical Endocrinology and Metabolism | 1962

Cause of Cushing's syndrome in patients with tumors arising from "nonendocrine" tissue.

Clifton K. Meador; Grant W. Liddle; Donald P. Island; Wendell E. Nicholson; Charles P. Lucas; John G. Nuckton; John A. Luetscher

Collaboration


Dive into the Charles P. Lucas's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David R. Rovner

Michigan State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G.H. Mayor

University of Michigan

View shared research outputs
Researchain Logo
Decentralizing Knowledge